Hińcza-Nowak, K.; Kowalik, A.; Walczyk, A.; Pałyga, I.; Gąsior-Perczak, D.; Płusa, A.; Kopczyński, J.; Chrapek, M.; Góźdź, S.; Kowalska, A.
CD276 as a Candidate Target for Immunotherapy in Medullary Thyroid Cancer. Int. J. Mol. Sci. 2023, 24, 10019.
https://doi.org/10.3390/ijms241210019
AMA Style
Hińcza-Nowak K, Kowalik A, Walczyk A, Pałyga I, Gąsior-Perczak D, Płusa A, Kopczyński J, Chrapek M, Góźdź S, Kowalska A.
CD276 as a Candidate Target for Immunotherapy in Medullary Thyroid Cancer. International Journal of Molecular Sciences. 2023; 24(12):10019.
https://doi.org/10.3390/ijms241210019
Chicago/Turabian Style
Hińcza-Nowak, Kinga, Artur Kowalik, Agnieszka Walczyk, Iwona Pałyga, Danuta Gąsior-Perczak, Agnieszka Płusa, Janusz Kopczyński, Magdalena Chrapek, Stanisław Góźdź, and Aldona Kowalska.
2023. "CD276 as a Candidate Target for Immunotherapy in Medullary Thyroid Cancer" International Journal of Molecular Sciences 24, no. 12: 10019.
https://doi.org/10.3390/ijms241210019
APA Style
Hińcza-Nowak, K., Kowalik, A., Walczyk, A., Pałyga, I., Gąsior-Perczak, D., Płusa, A., Kopczyński, J., Chrapek, M., Góźdź, S., & Kowalska, A.
(2023). CD276 as a Candidate Target for Immunotherapy in Medullary Thyroid Cancer. International Journal of Molecular Sciences, 24(12), 10019.
https://doi.org/10.3390/ijms241210019